Methamphetamine produces bidirectional, concentration-dependent effects on dopamine neuron excitability and dopamine-mediated synaptic currents

Journal of Neurophysiology

Volumn 108, Issue 3, 2012, Pages 802-809

  Branch, Sarah Y ^a   Beckstead, Michael J ^b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

D2 receptor; Dopamine transporter; G protein coupled inward rectifier K+channel; Mouse; Psychostimulant

Indexed keywords

AUTORECEPTOR; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; METHAMPHETAMINE;

ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN SLICE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG INDICATION; MALE; MESENCEPHALON; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ANIMALS; AUTORECEPTORS; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINERGIC NEURONS; MALE; MESENCEPHALON; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION;

EID: 84865654158     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.00094.2012     Document Type: Article

References (40)

1. Beckstead MJ, Gantz SC, Ford CP, Stenzel-Poore MP, Phillips PEM, Mark GP, Williams JT. CRF enhancement of GIRK channel-mediated transmission in dopamine neurons. Neuropsychopharmacology 34: 1926-1935, 2009.
2. Beckstead MJ, Grandy DK, Wickman K, Williams JT. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42: 939-946, 2004.
3. Beckstead MJ, Phillips TJ. Mice selectively bred for highor low-alcohol induced locomotion exhibit differences in dopamine neuron function. J Pharmacol Exp Ther 329: 342-349, 2009.
4. Brien JF, Kitney JC, Peachey JE, Rogers BJ. Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice. Res Commun Chem Pathol Pharmacol 22: 313-328, 1978.
5. Campbell AD, Kohl RR, McBride WJ. Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release. Alcohol 13: 569-574, 1996.
6. Chen J, Marmur R, Pulles A, Paredes W, Gardner EL. Ventral tegmental microinjection of delta 9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient. Brain Res 621: 65-70, 1993.
7. Chu PW, Hadlock GC, Vieira-Brock P, Stout K, Hanson GR, Fleckenstein AE. Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine release. J Neurochem 115: 325-332, 2010.
8. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278, 1988.
9. Erreger K, Grewer C, Javitch JA, Galli A. Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J Neurosci 28: 976-989, 2008.
10. Floresco SB, West AR, Ash B, Moore H, Grace AA. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6: 968-973, 2003.
11. Ford CP, Gantz SC, Phillips PE, Williams JT. Control of extracellular dopamine at dendrite and axon terminals. J Neurosci 30: 6975-6983, 2010.
12. Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26: 2788-2797, 2006.
13. Ford CP, Phillips PE, Williams JT. The time course of dopamine transmission in the ventral tegmental area. J Neurosci 29: 13344-13352, 2009.
14. Goodwin JS, Larson GA, Swant J, Sen N, Javitch JA, Zahniser NR, De Felice LJ, Khoshbouei H. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. J Biol Chem 284:2978-2989, 2009.
15. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4: 2877-2890, 1984.
16. Gulley JM, Zahniser NR. Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479: 139-152, 2003.
17. Han DD, Gu HH. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6: 6, 2006.
18. Ingram SL, Prasad BM, Amara SG. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5: 971-978, 2002.
19. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18: 1979-1986, 1998.
20. Kalivas PW, Duffy P. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J Neurochem 50: 1498-1504, 1988.
21. Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ. Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 4: 110-125, 2005.
22. Klitenick MA, DeWitte P, Kalivas PW. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci 12: 2623-2632, 1992.
23. Lacey MG, Mercuri NB, North RA. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J Physiol 392: 397-416, 1987.
24. National Institute on Drug Abuse. NIDA Research Report: Methamphetamine Abuse and Addition (NIH Publication No. 06-4210). Bethesda, MD: National Institute on Drug Abuse, 2006, p. 1-8.
25. Phillips PE, Stuber GD, Heien ML, Wightman RM, Carelli RM. Subsecond dopamine release promotes cocaine seeking. Nature 422: 614-618, 2003.
26. Rahman S, Zhang J, Corrigall WA. Effects of acute and chronic nicotine on somatodendritic dopamine release of the rat ventral tegmental area: in vivo microdialysis study. Neurosci Lett 348: 61-64, 1992.
27. Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE. Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 21: 1413-1419, 2001.
28. Schultz W. Behavioral theories and the neurophysiology of reward. Annu Rev Psychol 57: 87-115, 2006.
29. Seutin V, Verbanck P, Massotte L, Dresse A. Acute amphetamine-induced subsensitivity of A10 dopamine autoreceptors in vitro. Brain Res 558: 141-144, 1991.
30. Shi WX, Pun CL, Zhang XX, Jones MD, Bunney BS. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondop amine receptors. J Neurosci 20: 3504-3511, 2000.
31. Shi WX, Zhang XY, Pun CL, Bunney BS. Clozapine blocks D-amphetamineinduced excitation of dopamine neurons in the ventral tegmental area. Neuropsychopharmacology 32: 1922-1928, 2007.
32. Shoblock JR, Maisonneuve IM, Glick SD. Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacology (Berl) 170: 150-156, 2003a.
33. Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD. Neurochemical and behavioral differences between d-methamphetamine and d-amphet-amine in rats. Psychopharmacology (Berl) 165: 359-369, 2003b.
34. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG. Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17: 960-974, 1997.
35. Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69: 628-649, 2011.
36. Sulzer D, Maidment NT, Rayport S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60: 527-535, 1993.
37. Sulzer D, Sonders MS, Poulsen NW, Galli A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75: 406-433, 2005.
38. Yasumoto S, Tamura K, Karasawa J, Hasegawa R, Ikeda K, Yamamoto T, Yamamoto H. Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2. Neurosci Lett 454: 229-232, 2009.
39. Zombeck JA, Gupta T, Rhodes JS. Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice. Psychopharmacology (Berl) 201: 589-599, 2009.
40. Zweifel LS, Parker JG, Lobb CJ, Rainwater A, Wall VZ, Fadok JP, Darvas M, Kim MJ, Mizumori SJ, Paladini CA, Phillips PE, Palmiter RD. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci USA 106: 7281-7288, 2009.